about
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.Vitamins in the treatment of chronic viral hepatitis.Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.Review article: alcoholic liver disease--pathophysiological aspects and risk factors.Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II studyAdaptive response in hepatitis B virus infection.Chronic hepatitis B: Are we close to a cure?Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report.Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin.Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial.Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis.In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patients.Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor poolInfections and Organ TransplantationAntiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
P50
Q24814428-BE821943-CA4C-4956-A5AF-073EBA31DBA6Q33280133-EB0D16CA-5BDE-4E54-A327-8F31AC0BC374Q33800048-8B86459D-626E-48D8-87E0-89A937E28EADQ34764269-E598B659-C7A8-4C1D-86FF-70F0B6C4D6DEQ35594604-DFCC2278-740A-4236-8A30-E0D6F40917C4Q36609894-F3D36391-F349-468B-A691-51A3FED68CE3Q36949834-478DBFED-9414-4014-A497-FFCFC27D5BA4Q37481103-96D80987-C1FA-465D-BD81-D3C670DBD266Q38199811-12418E7F-1758-40AF-83F6-CCD876DB3BF4Q38542226-5891EC84-20BF-47E3-9827-4D7F28AB3ED6Q39540012-471BEF8B-D160-4B25-A3B2-655E28A75519Q41053182-51DF3EA6-0F6F-4CFF-9220-0F8D6391A7C1Q41965007-2E9A5103-2CC6-44EB-B394-9CFD01151546Q42236225-7F7A0D8C-6109-4C93-B03C-BEF10D9EB090Q42616157-AC436632-85EB-4646-932E-5BC527F87E7BQ42980409-ADD3208B-782B-4A2F-A3C2-3CED42199CBCQ42980441-42D5A02B-2AF2-4EAE-A76B-E7F6B061745BQ42982620-62E6EA0F-C373-4344-8A03-CDC0856D7D59Q42983710-DBEEC29E-4030-4E70-8186-3836DDA4C745Q42994537-A6532036-A46C-4760-A20B-09723455CCD1Q42996862-E973741D-B807-44CC-9182-31EF5AE1E956Q42997567-3F09BADF-D06F-4992-8377-AB1AC44137F4Q43030555-2A3E15C9-83B3-4115-8A18-A84B13CF9ADBQ43031107-D5E47A91-3132-4644-96CB-FFB49937F115Q43772289-573C32FF-5B65-4340-B76C-2EE37653A731Q43840047-4F348F3F-FEE5-4D44-8EBF-06097BBCE866Q43891215-067C278A-35E8-421F-966A-20B40215B798Q44806984-95C14D7E-F86C-428F-845C-5958168917E0Q44890581-8C2518B2-F9CA-439B-B725-077BD7946216Q45396648-7A41BA8B-7494-4F10-904E-D852928831C1Q46551826-40C92DFB-0EED-419E-B0D8-41881BBF1ACAQ46790482-4320FB0F-DEFB-4754-97C7-FFA5D58CA6D1Q51834866-76B877D6-4577-4CCD-A2C8-0A2DBD2FE894Q54585988-BD8C8582-81D4-4A92-B191-2AD7851904D2Q56982431-3A65D1EB-FEA3-4E52-9452-B41BB788BCF0Q57718848-E3999FCC-A53D-4660-B770-B01AB2FB1443Q58802765-0ADB60E3-78F4-4626-B276-3597685D92AD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elisabetta Loggi
@ast
Elisabetta Loggi
@en
Elisabetta Loggi
@es
Elisabetta Loggi
@nl
Elisabetta Loggi
@sl
type
label
Elisabetta Loggi
@ast
Elisabetta Loggi
@en
Elisabetta Loggi
@es
Elisabetta Loggi
@nl
Elisabetta Loggi
@sl
prefLabel
Elisabetta Loggi
@ast
Elisabetta Loggi
@en
Elisabetta Loggi
@es
Elisabetta Loggi
@nl
Elisabetta Loggi
@sl
P1053
K-7848-2016
P106
P1153
8681551300
P21
P31
P3829
P496
0000-0003-4985-9783